Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma69
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances56
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma43
Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment41
Advancement in transporter-oriented nanoplatforms for cancer therapy41
Polymyxin B delivery systems: smart solutions for improved antibacterial activity and reduced toxicity35
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis32
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches32
Chitosan–β-glycerophosphate thermogelling microneedles for transdermal contraceptive delivery of levonorgestrel28
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection28
Correction27
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer26
Improved antidiabetic potential of quercetin-loaded chitosan–lecithin nanoparticles for effective glycaemic control26
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells26
Emerging role of ferroptosis in diabetic retinopathy: a review25
Engineered extracellular vesicle with RAGE-antagonist peptide for delivery of anti-miRNA155 oligonucleotides to inflammatory lung cells23
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases23
Correction23
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes23
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review22
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer22
Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets21
Ferroptosis-targeting drugs in breast cancer21
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice21
1.5611979961395